Advertisement: TTP Killer 50
30 December, 2014 - 10:47 By News Desk


F-star, biopharma, antibodies, cambridge

Antibodies specialist F-star won the Life Science Innovation category, sponsored by AstraZeneca and MedImmune, at the March 2017 Business Weekly Awards.

F–star is a biopharmaceutical company focused on developing immuno-oncology bispecific antibody therapeutics. 

It is poised to dominate the bispecific antibody space in immuno-oncology through the application of highly efficient Modular Antibody Technology™ platform. This powerful platform enables the discovery of novel bispecific antibodies, which are selected for their potential to transform the treatment of cancer.


Newsletter Subscription

Stay informed of the latest news and features